Viewing StudyNCT01672736



Ignite Creation Date: 2024-05-06 @ 12:51 AM
Last Modification Date: 2024-10-26 @ 10:55 AM
Study NCT ID: NCT01672736
Status: TERMINATED
Last Update Posted: 2018-09-13
First Post: 2012-08-01

Brief Title: A Trial of ASP7487 OSI-906 in Combination With Bortezomib for the Treatment of Relapsed Multiple Myeloma
Sponsor: University Health Network Toronto
Organization: University Health Network Toronto

Organization Data

Organization: University Health Network Toronto
Class: OTHER
Study ID: PMHOSI906-MM001
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor: University Health Network Toronto
Lead Sponsor Class: OTHER
Responsible Party: None
Responsible Party Title: None
Responsible Party Type: SPONSOR
Responsible Party Affiliation: None
Old Name: None
Old Organization: None

Collaborators

Name Class
Astellas Pharma Inc INDUSTRY
Multiple Myeloma Research Consortium NETWORK